From investors to startups to the world’s largest healthcare companies, clients turn to us on a full range of transactions and other legal matters.
Companies appreciate our depth of experience in areas including pharmaceuticals, biotechnology, and diagnostic and medical devices. Since 2010, we have completed more than 900 capital markets transactions in healthcare, totaling over $2.5 trillion. Over the same period, we have advised on more than 300 M&A transactions, with a cumulative deal value of approximately $1.5 trillion and a market share of nearly 21%, according to data from LSEG Data & Analytics.
Healthcare and life sciences clients trust in our understanding of the complex issues they face in acquisitions, divestitures, joint ventures, partnerships, strategic alliances, licensing arrangements, collaborations, distribution agreements, internal investigations and litigation.
Many transactions and other matters have an intellectual property component. Clients appreciate that our team includes lawyers with strong biomedical backgrounds such as Ph.D.s and biomedical engineering degrees.
Highlight
$2.5+ trillion
Aggregate value of more than 900 capital markets transactions since 2010
Source: LSEG Data & Analytics
Featured practices
Capital Markets
We work with top multinationals and are a firm of choice for companies going public. IPOs include ACELYRIN, American Well, Bausch + Lomb, BioNTech, CureVac, GoodRx, Hinge Health, Signify Health and Royalty Pharma.
Mergers & Acquisitions
M&A clients range from pharmaceutical innovators to medical device companies, including Bausch Health, Bristol Myers Squibb, Charles River, Endo, Gilead, GSK, Novo Nordisk, Pfizer, Roche and Smith+Nephew.
Finance
We advise healthcare and life sciences companies and credit arrangers on bridge facilities, term loans and revolving credit facilities on their most significant and complex financing transactions.
IP & Commercial Transactions
We advise companies across life sciences on complex commercial agreements – including licensing, JV, R&D, supply and distribution – with a team that understands the technology, including lawyers with Ph.D.s.
Litigation
We advise clients on litigation and enforcement involving alleged bribery, false advertising and fraud, product safety violations, off-label promotion and patent misuse, as well as securities litigation.